BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1085193)

  • 1. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative cell-mediated immune status of gastric cancer patients.
    Orita K; Miwa H; Fukuda H; Yumura M; Uchida Y
    Cancer; 1976 Dec; 38(6):2343-8. PubMed ID: 793709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immune competence of patients with Crohn's disease (author's transl)].
    Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
    Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.
    Froebel K; Sturrock RD; Dick WC; MacSween RN
    Clin Exp Immunol; 1975 Dec; 22(3):446-52. PubMed ID: 1083785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
    Alsabti EA
    Oncology; 1979; 36(4):171-5. PubMed ID: 157453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T rosettes in alcoholic cirrhosis of the liver.
    Berenyi MR; Straus B; Avila L
    JAMA; 1975 Apr; 232(1):44-6. PubMed ID: 1090766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
    Pritchard DJ; Ritts RE; Taylor WF; Miller GC
    Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective cell-mediated immunity in carcinoma of the prostate.
    Thomas JW; Jerkins G; Cox C; Lieberman P
    Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.
    Brooks WH; Roszman TL; Rogers AS
    Cancer; 1976 Apr; 37(4):1869-73. PubMed ID: 769940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
    Sasaki T; Fujisaki S
    Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity.
    Baskies AM; Chretien PB; Weiss JF; Makuch RW; Beveridge RA; Catalona WJ; Spiegel HE
    Cancer; 1980 Jun; 45(12):3050-60. PubMed ID: 7388749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity in squamous cell carcinoma of the uterine cervix.
    Levy S; Kopersztych S; Musatti CC; Souen JS; Salvatore CA; Mendes NF
    Am J Obstet Gynecol; 1978 Jan; 130(2):160-4. PubMed ID: 304309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cell-mediated immunity function in thyroid cancer.
    Liaw KY; Chang-Chien Y; Chen YC; Deng JS
    Cancer; 1980 Jul; 46(2):285-8. PubMed ID: 6966963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact sensitivity to DNCB in normal and cell-mediated-immunity deficient chickens: in vivo detection and correlation with lymphocyte transformation and graft-versus-host reaction.
    Tiwary BK; Goel MC
    Vet Immunol Immunopathol; 1985 Apr; 8(4):329-39. PubMed ID: 3873745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
    J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity in Hurler's syndrome.
    Mendes E; Toledo SP
    Allergol Immunopathol (Madr); 1975; 3(2):95-8. PubMed ID: 808113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.